As-CA11
As-CA11 is a Thioredoxin reductase (TrxR) inhibitor with an IC50 of 18.7 nM. As-CA11 is shows potent inhibitory activities against HeLa, HepG2, A549 and HL-60 cells with IC50 of 0.35, 0.3, 0.43 and 0.28 μM. As-CA11 can induce cancer cells apoptosis and ROS production. As-CA11 can reduce the level of reduced Trx and increase the level of oxidized Trx. As-CA11 demonstrates anti-tumor activity in the 4T1 tumor-bearing mouse model[1].
Product Specifications
UNSPSC
12352100
Target
Apoptosis; Reactive Oxygen Species (ROS) ; TrxR
Related Pathways
Apoptosis; Immunology/Inflammation; Metabolic Enzyme/Protease; NF-κB
Field of Research
Cancer
Smiles
ClC1=CC=CC(Cl)=C1/C=C/C(NC2=CC=C([As]3SCCCS3)C=C2)=O
Molecular Formula
C18H16AsCl2NOS2
Molecular Weight
472.28
References & Citations
[1]Shi S, et al. Structure-Guided optimization of PAO-PDT yields TrxR inhibitors as potential anticancer agent. Eur J Med Chem. 2026 Feb 5;303:118407.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
CD100 (Semaphorin-4D) (A8), CF405S conjugate, 0.1mg/mL
CD44 Standard (156-3C11), CF488A conjugate, 0.1mg/mL
E-Cadherin / CD324 (Intercellular Junction Marker) (4A2), CF640R conjugate, 0.1mg/mL
S100B (Astrocyte and Melanoma Marker) (S100B/1706R), CF405S conjugate, 0.1mg/mL
CD3e (T-Cell Marker) (C3e/2478), CF568 conjugate, 0.1mg/mL
